-
1Academic Journal
المؤلفون: Crokart, Nathalie, Danhier, Fabienne, Daugimont, Liévin, Gonçalves, Nelio, Jordan, Bénédicte, Grégoire, Vincent, Feron, Olivier, Bouquet, Céline, Gallez, Bernard, Préat, Véronique
المساهمون: UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - SSS/IREC/FATH - Pôle de Pharmacologie et thérapeutique, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service de radiothérapie oncologique, UCL - (SLuc) Service de médecine nucléaire
المصدر: Radiotherapy & Oncology, Vol. 107, no. 2, p. 252-258 (2013)
مصطلحات موضوعية: Antiangiogenesis, Gene therapy, Radiosensitization, Cancer, Electrotransfer, Tumor microenvironment
Relation: boreal:128204; http://hdl.handle.net/2078.1/128204; info:pmid/23623728; urn:ISSN:0167-8140; urn:EISSN:1879-0887
-
2Academic Journal
المؤلفون: Crokart, Nathalie, Danhier, Fabienne, Daugimont, Liévin, Gonçalves, Nelio, Jordan, Bénédicte, Grégoire, Vincent, Feron, Olivier, Bouquet, Céline, Gallez, Bernard, Préat, Véronique
المساهمون: UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - SSS/IREC/FATH - Pôle de Pharmacologie et thérapeutique, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service de radiothérapie oncologique, UCL - (SLuc) Service de médecine nucléaire
المصدر: Radiotherapy & Oncology, Vol. 107, no. 2, p. 252-258 (2013)
مصطلحات موضوعية: Antiangiogenesis, Gene therapy, Radiosensitization, Cancer, Electrotransfer, Tumor microenvironment
Relation: boreal:128204; http://hdl.handle.net/2078.1/128204; info:pmid/23623728; urn:ISSN:0167-8140; urn:EISSN:1879-0887
-
3Academic Journal
المؤلفون: Daugimont, Liévin, Vandermeulen, Gaëlle, Defresne, Florence, Bouzin, Caroline, Mir, Lluis M., Bouquet, Céline, Feron, Olivier, Préat, Véronique
المساهمون: UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - SSS/IREC/FATH - Pôle de Pharmacologie et thérapeutique, Cnrs - - Institut Gustave Roussy, Bioalliance Pharma - Bioalliance Pharma - Paris France, UCL - SSS/IREC - Institut de recherche expérimentale et clinique
المصدر: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 78, no. 3, p. 314-9 (2011)
مصطلحات موضوعية: Transfection, Thrombospondin 1, Survivors, Receptors, Vascular Endothelial Growth Factor, Plasmids, Neovascularization, Pathologic, Mice, Inbred C57BL, Membrane Proteins, Melanoma, Experimental, Male, Gene Therapy, Electroporation, Disintegrins, Animals, Angiogenesis Inhibitors, ADAM Proteins, Antiangiogenic plasmid, Disintegrin domain of ADAM15
Relation: boreal:79871; http://hdl.handle.net/2078.1/79871; info:pmid/21316447; urn:ISSN:0939-6411; urn:EISSN:1873-3441
-
4Academic Journal
المؤلفون: Daugimont, Liévin, Vandermeulen, Gaëlle, Defresne, Florence, Bouzin, Caroline, Mir, Lluis M., Bouquet, Céline, Feron, Olivier, Préat, Véronique
المساهمون: UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - SSS/IREC/FATH - Pôle de Pharmacologie et thérapeutique, Cnrs - - Institut Gustave Roussy, Bioalliance Pharma - Bioalliance Pharma - Paris France, UCL - SSS/IREC - Institut de recherche expérimentale et clinique
المصدر: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 78, no. 3, p. 314-9 (2011)
مصطلحات موضوعية: Transfection, Thrombospondin 1, Survivors, Receptors, Vascular Endothelial Growth Factor, Plasmids, Neovascularization, Pathologic, Mice, Inbred C57BL, Membrane Proteins, Melanoma, Experimental, Male, Gene Therapy, Electroporation, Disintegrins, Animals, Angiogenesis Inhibitors, ADAM Proteins, Antiangiogenic plasmid, Disintegrin domain of ADAM15
Relation: boreal:79871; http://hdl.handle.net/2078.1/79871; info:pmid/21316447; urn:ISSN:0939-6411; urn:EISSN:1873-3441